Adverum Biotechnologies to Present At Phacilitate Cell & Gene Therapy World 2017 – EIN News (press release)
|
Adverum Biotechnologies to Present At Phacilitate Cell & Gene Therapy World 2017
EIN News (press release) 18, 2017 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq:ADVM) a gene therapy company committed to discovering and developing novel medicines for patients suffering from diseases with few or burdensome treatment options, announced … |
